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Magnetite nanoparticles
for medical MR imaging
Nanotechnology has given scientists new tools for the development of
advanced materials for the detection and diagnosis of disease. In particular,
superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively
investigated as novel magnetic resonance imaging (MRI) contrast
agents due to a combination of favorable superparamagnetic properties,
biodegradability, and surface properties. This review discusses the basics
of MR imaging, the origin of SPION’s unique magnetic properties, recent
developments in MRI acquisition methods for detection of SPIONs,
synthesis and post-synthesis processes that improve SPION’s imaging
characteristics, and the outlook of the translational potential of SPIONs.
Zachary R. Stephen, Forrest M. Kievit, and Miqin Zhang*
Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA
*E-mail: mzhang@u.washington.edu
Magnetic resonance imaging (MRI) has become one of the

Among the various MNPs under investigation, superparamagnetic

most widely used and powerful tools for non-invasive clinical

iron oxide nanoparticles (SPIONs) have attracted considerable interest

diagnosis due to its high soft tissue contrast, spatial resolution,

due to their excellent magnetic properties, biocompatibility6 and

and penetration depth1. In addition, images are acquired without

biodegradability7. While the in vivo applications of many nanoparticle-

the use of ionizing radiation or radiotracers that would cause

based contrast agents are hampered by toxicity concerns, SPIONs

unwanted harmful side-effects. A considerable amount of research

of several formulations have been approved by the Food and Drug

in medical MR imaging is focused on the development of contrast

Administration (FDA) as MRI contrast agents. These include Lumiren®

agents that can provide better delineation between healthy and

for bowel imaging8, Feridex IV® for liver and spleen imaging9, and

diseased tissue. Magnetic nanoparticles (MNPs) are a major class

Combidex® for lymph node metastases imaging10. Recent advances

of nanoscale material currently under extensive development for

in this field have further improved the magnetic and physiochemical

improved diagnosis of a wide range of diseases, including cancer2,

properties of SPIONs11, broadening their potential clinical applications.

cardiovascular disease3, and neurological disease4. The nanoscale
dimensions of MNPs give rise to unique magnetic properties and
the ability to function on a cellular and molecular
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level5.

It is

MR and relaxation properties of SPIONs
Principles of MRI contrast

the combination of these characteristics that make MNPs such

MRI employs a strong magnetic field that aligns the magnetic moments

promising contrast agents for MRI applications.

of protons in a sample producing an equilibrium magnetization along
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the z-axis (Mz) with a magnitude of M0. A radio frequency (RF) pulse, at
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In most tissue, intrinsic variations of T1 and T2 are small and often

a resonant frequency capable of transferring energy to protons, rotates

exogenous materials are employed clinically to enhance the contrast

their magnetic moments away from the z-axis, in phase, to an angle

between the tissue of interest and the surrounding tissue. While nearly

called the flip angle. The choice of flip angle depends on the imaging

all MRI contrast agents affect both T1 and T2, usually the effects of

sequence applied, but it is generally the transverse plane (xy-plane),

contrast agents are more pronounced for either T1 or T2, leading to the

causing a net magnetization of Mxy. Upon removal of the RF, the

categorization of these probes as T1 or T2 contrast agents. T1 contrast

magnetic moments of the protons relax to equilibrium1,12. The time

agents are used to increase signal intensity providing positive contrast

required for the magnetic moments to relax to the equilibrium state,

enhancement in T1 weighted images, whereas, T2 contrast agents

which is broadly termed the relaxation time, is tissue-dependent.

decrease signal intensity resulting in a negative contrast enhancement

MRI contrast in soft tissue is due to differences in the proton

in T2 weighted images. Currently, the most widely used clinical

density, spin-lattice relaxation time (T1) and spin-spin relaxation

contrast agents are based on paramagnetic chelates of lanthanide

time (T2) of the protons. T1 is the time constant of the exponential

metals such as gadolinium14. The presence of paramagnetic ions near

recovery process of M0 along the z-axis after an RF pulse. Protons that

water protons shortens their T1 relaxation time through coordination

relax rapidly (short T1) recover full magnetization along the z-axis and

with water molecules providing increased contrast. While gadolinium

produce high signal intensities. For protons that relax more slowly (long

chelates are widely used, their short blood circulation times, poor

T1), full magnetization is not recovered before subsequent RF pulses,

detection sensitivity, and toxicity concerns have led to the continued

and so they inherently produce less signal and result in the so-called

development of SPIONs for T2 contrast enhancement15,16.

saturation effect. T1 weighted images illustrate anatomy well and are
preferred when a clear image of the structure is required12.
T2 is the time constant of the exponential decay of the transverse

Magnetic properties of SPIONs
The unique magnetic properties of SPIONs arise from a combination of

magnetization (Mxy) after an RF pulse. T2 is related to the amount

their atomic composition, crystal structure, and size effects. Bulk iron

of time for the precessing magnetic moments of protons to become

oxide consists of both Fe2+ and Fe3+ atoms and exhibits ferromagnetic

randomly aligned in the xy-plane after an RF pulse, eventually resulting

behavior. Large ferrimagnetic crystals of Fe3O4 are comprised of

in a net magnetic moment of zero in the xy-plane. This dephasing

multiple magnetic domains that exhibit magnetic moments that are

process can be caused by a combination of local inhomogeneities in the

aligned within a domain, but between domains, magnetic moments

magnetic field due to magnetic interactions of neighboring molecules

are oriented in random directions17. Ferrimagnetic particles below

and by macroscopic effects related to subtle variations in the external

a critical diameter consist of a single magnetic domain. The critical

magnetic field. When the dephasing time accounts for both intrinsic

diameter, defined as the size at which domain boundaries are no

molecular interactions and extrinsic magnetic field inhomogeneities

longer energetically favorable, is highly dependent on the anisotropy

it is termed T2*, and the images produced are considered to be

of the particles, and varies for different materials18-20. For spherical

T2* weighted. T2 weighted images are produced by eliminating the

magnetite iron oxide (Fe3O4) the critical diameter is approximately

dephasing effects caused by extrinsic magnetic field inhomogeneities

70 – 150 nm18,20,21. When the diameter of spherical magnetite

and accounting for the molecular interactions alone. T2 weighted images

particles is reduced below approximately 20 nm20, the thermal energy

produce good pathological information since collections of abnormal

available at room temperature is greater than the magnetostatic

fluid appear bright against the normal tissue background1.

energy well barrier. The magnetic dipole is free to fluctuate and as

Spin-echo (SE) pulse sequences are used to eliminate external

a consequence the particle acts like a paramagnetic Fe(2+,3+) atom.

magnetic field effects and can generate T1 or T2 weighted images

Since a nanoparticle comprises thousands of atoms it is described

based purely on molecular interactions1. This signal eliminates extrinsic

as superparamagnetic; it combines the high magnetization of bulk

effects and provides quantitative T2 data for T2 weighted images. In

magnetite with the paramagnetic nature of Fe ions (Fig. 1).

its most basic form, the spin-echo scans employ two RF pulses with
flip angles of 90° and 180° that produce a spin echo. The 180° pulse

Effects of SPIONs on MRI contrast

serves to refocus the transverse magnetization, cancelling dephasing

SPIONs primarily act to alter T2 values of the water protons

effects caused by inhomogeneities in the local magnetic field. The time

surrounding the particle. When SPIONs present in tissue are subject to

between the application of the 90° pulse and the peak of the echo

an external magnetic field the large magnetic moments of the particles

signal is termed the echo time (TE). Both TE and the time between RF

align to create large heterogeneous field gradients through which

pulse repetitions (TR) are responsible for the type of image produced.

water protons diffuse. The dipolar coupling between the magnetic

T1 weighted images are produced by selecting short TR (250 – 700 ms)

moments of water protons and the magnetic moments of particles

and short TE (10 – 25 ms), while T2 weighted images are produced by

cause efficient spin dephasing and T2 relaxation leading to a decrease

long TR (> 2000 ms) and long TE (> 60 ms)13.

in signal intensity22. The contrast provided by SPIONs in a T2 weighted
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Fig. 1 The effects of an external magnetic field on bulk magnetite (top), Fe ions (middle), and SPIONs (bottom). Before application of the magnetic field all
magnetic moments are randomly aligned. Application of an external magnetic field aligns the moments along the z-axis of the magnetic field. The initial net
magnetization of SPIONs is greater than Fe ions, but less than bulk magnetite. Upon removal of the magnetic field, the moments of bulk magnetite remain fixed
along the z-axis while both Fe ions and SPIONs magnetic moments relax over time to equilibrium.

image is termed negative contrast enhancement since areas with high

imaging of brain tumors. Common clinical gadolinium chelates such

concentrations of SPIONs appear dark on MR images.

as gadolinium diethylenetriamine penta-acetic acid (Gd-DTPA) cannot

While SPIONs provide efficient shortening of T2 and generate

traverse the blood-brain barrier (BBB) without the use of invasive

excellent contrast enhancement in tissue with longer T2

techniques30,31, limiting their application in brain tumor imaging. A

characteristics, signal loss due to the presence of SPIONs can make

significant advantage of SPIONs is their relatively large surface area

it difficult to distinguish contrast enhancement in low signal body

which allows for the efficient addition of biologically active moieties

regions23,24. Senpan et al. have recently reported a T1 weighted

such as BBB-penetrating peptides for non-invasive brain tumor

colloidal cross-linked iron oxide nanoparticle comprised of oleate-

imaging. For example, Veiseh et al. have shown that SPIONs labeled

coated magnetite particles within a cross-linked phospholipid

with chlorotoxin (CTX) peptide, a targeting agent with high affinity for

nanoemulsion25.

tumors of neuroectodermal origin through binding of the membrane-

This formulation decreased T2 effects and allowed

positive T1 weighted contrast detection at nanomolar concentrations.

bound matrix metalloproteinase-2 complex, can pass the BBB and

Additionally, ultrasmall superparamagnetic iron oxide (USPIO), i.e.,

successfully target brain tumors in a transgenic mouse model32-35.

SPIONs with core diameters less than 10 nm, are capable of producing

The exclusion of Gd-DTPA from the parenchymal region signifies that

positive contrast in T1 weighted images26,27. While positive T1

the BBB is not compromised before or after the administration of CTX

contrast is possible with USPIO, this benefit is at the expense of their

labeled SPIONs (Fig. 2), and highlights one advantage of SPIONs over

T2 effects18,28.

commonly used Gd-chelates.

Another approach that has recently been investigated is the
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addition of a gadolinium chelate on the polymer coating of SPIONs29.

MRI acquisition methods for improved SPION detection

This dual contrast agent efficiently reduces both T1 and T2 relaxation

The detectability of SPIONs in vivo can be improved through synthesis

times and achieves good contrast in mice for both T1 and T2 weighted

techniques that enrich their magnetic properties (further discussed

images. This unique combination allows for the acquisition of both

under “Important SPION design parameters” below), and through

highly detailed T1 weighted anatomical images and pathologically

enhanced MRI acquisition methods that improve SPION detection.

relevant T2 weighted images with a single imaging nanoprobe. In

Acquisition methods that achieve low detection limits will be essential

addition, such a contrast probe could provide enhanced T1 weighted

as the next generation of SPIONs move toward clinical application.

JULY-AUGUST 2011 | VOLUME 14 | NUMBER 7-8
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Lower detection limits will allow for administration of lower SPION

weighted methods, new techniques that generate positive contrast

dosages while improving contrast. In addition to methods that

enhancements are currently being developed.

improve the negative contrast enhancement inherent to traditional T2

Historically, MRI acquisition methods for the detection of
SPIONs have been based on T2 weighted SE pulse sequences and T2*
weighted gradient echo (GRE) pulse sequences that give quantitative

(a)

and qualitative information about the location of SPIONs in vivo,
respectively36-38. Recently, an effort to improve detection limits has led
to the modification of traditional SPION pulse sequences37, as well as
the application of nontraditional SPION pulse sequences such as fluid
attenuated inversion-recovery (FLAIR)39,40.
The sensitivity of MRI in the detection of single SPION loaded
cells increases linearly with increasing resolution and increases
(b)

hyperbolically with increasing signal-to-noise ratios (SNR)37. Based
on this observation, imaging with both high resolution and high
SNR would give the greatest SPION detection capabilities; however,
increasing resolution and SNR, both of which increase image
acquisition time, would result in unreasonably long acquisition times.
Since there are diminishing returns in increasing SNR, reduction
in voxel (volumetric pixel) size should be of primary concern to
maintain acceptable imaging times. With this in mind, Hyen et al.

(c)

used fast imaging employing a steady-state acquisition (FIESTA)
sequence based on a GRE pulse sequence that was able to detect
femtomole quantities of SPIONs in labeled single cells in vitro37. With
this pulse sequence, images are weighted by a ratio of T2 and T1,
and detection limits are comparable to those of positron emission
tomography (PET)41.
The fluid-attenuated inversion recovery (FLAIR) sequence was

Fig. 2 Comparison of the BBB permeating ability of Gd-DTPA and NPCP-CTX.
(a) T1 weighted MR images of N2:SmoA1 mice before and 5 min after the
injection of Gd-DTPA. (b) colorized R2 (1/T2) maps superimposed onto proton
density–weighted images obtained before and 48 h after the injection of
NPCP-CTX. (c) T1 weighted MR images of N2:SmoA1 mice before and 5 min
after the injection of Gd-DTPA obtained 48 h after NPCP-CTX administration.
Arrows indicate blood vessels. Reprinted with permission from32, © 2010
American Association for Cancer Research.

(a)

(b)

developed to nullify signals from fluid and has been shown to be useful
in the diagnosis of central nervous system diseases42. This sequence
first inverts the magnetic moments of protons in the z-axis before
an additional 90° RF pulse at time TI (time between 180° and 90°
RF pulse) tilts the magnetic moments into the xy-axis. This process
can attenuate both tissue and/or fluid based on the chosen TI, but

(c)

Fig. 3 Signal variation among adjacent slices (a–c) from an in vivo 3T FSE 3D IRON acquisition obtained in an ischemic rabbit hindlimb with two injection sites of SPIONlabeled stem cells (250 000 cells: dotted white arrow, 125 000 cells: solid white arrow). Excellent background suppression leads to clear visualization of the stem cell
injection sites with positive contrast and a larger volume of hyperintense signals for the 250 000 cell injection site. The dashed white arrow indicates imperfections in both
the on-resonant water suppression and off-resonant fat suppression. Reprinted with permission from43. © 2007 John Wiley & Sons.
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suffers from long imaging times. Fukukura et al. recently demonstrated

Core considerations

the effectiveness of a more rapid FLAIR echo-planar imaging (FLAIR EPI)

Synthesis methods of SPIONs have a dramatic effect on their

sequence39,40

crystallinity. The two most common methods are co-precipitation51-53

contrast

for the detection of malignant liver lesions with SPION

enhancement42.

By suppressing signals from cysts, vascular

and thermal decomposition54,55. Synthesis of SPIONs by

structures, and periportal tissue, the FLAIR EPI sequence was more

co-precipitation of Fe2+ and Fe3+ in aqueous solutions has traditionally

sensitive for the detection malignant liver tumors than either the T2

been the most utilized synthesis method56. This method typically

weighted SE pulse sequences or the T2* weighted GRE pulse sequences

results in a lack of well-defined nanocrystalline size, stoichiometry,

in human patients.

and magnetism28,57. Furthermore, the production often yields both

Limitations of T2 contrast in low signal tissues have led to the

maghemite (Fe2O3) and magnetite. Magnetite is preferred of the two

development of specific pulse sequences that produce positive contrast

materials because of its superior magnetic properties58. Synthesis

in the presence of SPIONs. These methods attenuate the background

parameters of the co-precipitation method must be rigorously

signal so that only fluid and tissue immediately adjacent to SPIONs are

controlled so that nanocrystalline magnetite is the major product to

visible in MR images (Fig. 3). The current positive contrast sequences

maintain acceptable MR signal-enhancing effect. Thermal decomposition

are classified as selective RF pulse methods43-45, dephased methods46,

of iron organometallic compounds is a more recent approach that

and off-resonance

methods47.

Selective RF pulse methods, such

produces monocrystalline particles of stoichiometric magnetite59. The

as inversion-recovery with on-resonant water suppression (IRON),

high temperatures of the thermal decomposition method allows for a

employ inversion of magnetization in conjunction with a spectrally-

higher rate of diffusion during the growth phase of the SPIONs resulting

selective on-resonant saturation pre-pulse that only generates signal

in improved magnetic properties that demonstrate high relaxivity.

from off-resonant protons in close proximity to SPIONs. Dephased

The core size of SPIONs has significant effects on relaxivity properties.

methods employ a slice gradient in the region near the SPION that

The thermal decomposition synthesis method produces SPIONs with

dephase background signal protons, but conserve signal from protons

highly controllable, monodisperse size distributions. Through minor

surrounding the SPION due to their induced magnetic field. Off-

modifications to synthesis parameters, SPIONs with mean diameters

resonance methods utilize spectrally selective RF pulses that excite
and refocus the off-resonance water surrounding SPIONs, while

(a)

suppressing on-resonance signals from surrounding tissue. In addition
to positive contrast sequences, post-processing methods that do not
require special sequences for acquisition of positive contrast images
have been developed48,49. Liu et al. compared a post-processing
susceptibility-gradient mapping (SGM) technique to IRON and the
White Marker (dephased method) positive contrast sequences50. SGM
more clearly delineates glioma tumors labeled with SPIONs than either

(b)

the IRON or White Marker sequences in rats. Nevertheless, further
studies are needed to compare the detection limit of the various
positive contrast methods with those of the traditional spin echo

(c)

methods.

Important SPION design parameters

(d)

(e)

The magnetic properties of the SPION are affected by the crystallinity
and size of the magnetite core. In addition, surface modifications
including polymer coatings and tissue targeting agents can have a
profound effect on the efficiency of SPIONs as MRI contrast agents.
These modifications can increase local concentrations of SPIONs in
the tissue of interest while decreasing the concentration in background
tissue. The efficiency of these contrast agents to increase the rate of
relaxation of surrounding protons can be expressed by the relaxivity (r1,
r2), which is defined as the slope of the plot 1/T1 or 1/T2 as a function
of SPION concentration. By carefully considering the parameters of
core synthesis and post synthesis modifications, materials with superior
relaxivity properties and in vivo kinetics can be produced.
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Fig. 4 Nanoscale size effects of water soluble iron oxide nanocrystals on
magnetism and induced MR signals. (a) TEM images of Fe3O4 nanocrystals of
4, 6, 9, and 12 nm. (b) Size dependent T2 weighted MR images of nanocrystals
in aqueous solution at 1.5 T. (c) Size dependent changes in color-coded MR
images based on T2 values. (d) Graph of T2 value versus nanocrystal size.
(e) Magnetization of nanocrystals measured by a SQUID magnetometer.
Reprinted with permission from28. © 2005 American Chemical Society.
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ranging from 4 nm to 20 nm can be produced with a narrow size

yet this effect is not observed when coupling is performed with

distribution60. Fig. 4 illustrates the correlation between particle size and

phosphonates62. Additionally, the use of hydrophilic molecules such as

T2 relaxation due to changes in magnetic properties. As particle size is

polyethylenimine (PEI) as capping ligands allows for greater hydration

reduced there is a corresponding reduction in saturation magnetization

around the magnetic core and yields higher proton relaxivity than

which in turn reduces the T2 relaxation capabilities of SPIONs. This

SPIONs capped with hydrophobic ligands such as oleic acid69.

phenomenon is a result of increased surface-to-volume ratios due to

Polymer chain length, which corresponds to coating thickness,

decreased particle diameter. As particle size is reduced, the percentage

also has significant effects on relaxivity. Computer simulations have

of atoms found on the particle surface increases and the curvature of

shown the effect of coating thickness on relaxivity is determined by

the particle surface considerably increases, resulting in significant surface

two competing factors: the physical exclusion of protons from the

effects. The atoms on the surface have a reduction in nearest neighbors

SPION’s magnetic field and the residence time for protons within the

resulting in unsatisfied bonds, as well as noncollinear spins, spin canting,

coating zone70. The structure of the coating layer determines which

and spin-glass-like behavior. These effects can severely diminish the

factor dominates. LeConte et al. studied the effects of chain length

saturation magnetization of small SPIONs by reducing the number of

on relaxivity for SPIONs with a bilayer coating70. In this system, the

atoms that contribute efficiently to the particle’s magnetic moment61.

inner hydrophobic layer excludes water, while the outer hydrophilic
PEG layer allows for water diffusion in the coating zone. Increasing

Surface modifications

PEG chain length led to a reduction in r2 values. Here it seems that the

Surface coating

exclusion of water from the core by the inner hydrophobic layer more

Passivation of the iron oxide core is necessary for successful application

than offsets any effect caused by increasing the hydrophilic PEG layer

of SPIONs in vivo. The high surface-to-volume ratio of nanoparticles

thickness. Recent studies by Hu et al. have shown that when water

yields high surface energies, fascilitating surface oxidation which can

molecules are not excluded from regions close to the SPION core,

have a significant effect on the magnetic properties of SPIONs58,61,62.

r2 relaxivity is increased with increased chain length71. SPIONs with

In addition to surface oxidation, high surface energies can lead to

diameters of 3, 4, 5, and 6 nm were coated with a single polymer layer

particle aggregation or clustering in physiological environments63.

of either short chain diethylene glycol or long chain PEG. Modification

Modification approaches for surface passivation of SPION cores

with PEG leads to an increase from 29 to 47, 42 to 69, 48 to 86, and

generally provide a reduction in surface energy as well as either

61 to 119 mM−1s−1 for the four SPION diameters respectively. These

steric or electrostatic repulsion. Upon intravenous injection, SPIONs

differences can be attributed to a larger water-slow diffusion layer of

are subjected to protein adsorption, or opsonization, in the first step

PEG modified SPIONs. Measurements of water diffusion coefficients

toward clearance from the blood stream by the reticuloendothelial

in solutions of PEG of varying molecular weights indicate that water

system (RES). Evading RES uptake increases the blood half-life of

moves more slowly in more highly concentrated PEG environments72.

SPIONs which is crucial for many MRI applications, as increased

Protons in the slow water diffusion layer spend a longer period of time

blood-circulation time maximizes the odds of SPIONs reaching their

in close proximity to the magnetic field of the SPION core allowing

target tissue. A common technique to avoid opsonization and eventual

for more efficient dephasing of the magnetic moments of neighboring

clearance by the RES is to utilize hydrophilic coatings64 such as

protons.

poly(ethylene glycol) (PEG)65 and zwitterionic66 polymers that resist
protein fouling.

Targeting agents

Many materials and coating approaches have been utilized for

Contrast agents that specifically target tissue can increase SNR by

modifying the surface of SPIONs. Polymers are the most widely used

increasing local SPION concentration, potentially allowing for earlier

coating materials and can be classified as hydrophilic or amphiphilic,

detection of disease tissue such as small solid tumors and metastatic

neutral or charged, homopolymers or

copolymers67,68.

These polymers

cells. Early SPIONs relied on passive targeting through the enhanced

can be anchored on the iron oxide surface by hydrogen bonds,

permeation and retention (EPR) effect which is the primary route for

electrostatic forces or through pseudo-covalent bonding16. In general,

passive targeting in solid tumors. The EPR effect aids in nanoparticle

the coating should provide the SPION with a hydrophilic exterior to

uptake by way of leaky vasculature which allows particles with a

increase water solubility and stability.

hydrodynamic size generally less than 100 nm in diameter to cross

The choice of coating material can have a significant effect on
the relaxivity of SPIONs. The coordination chemistry of the inner
capping ligand(s) and the hydrophilicity of the coating layer are
important factors on particle

relaxivity62,69.

from the vasculature into the interstitium73,74. Poor lymphatic drainage
then aids in the entrapment of particles in solid tumors.
Alternatively, active targeting strategies provide mechanisms for

Daou et al. have shown

the specific accumulation of contrast agents within diseased tissue or

that the coupling of surface coatings with the core of the SPION by

cells. These strategies are based on the targeting of unique molecular

carboxylates leads to spin canting and decreased net magnetization,

signatures of afflicted cells, such as over-expressed growth factors and

JULY-AUGUST 2011 | VOLUME 14 | NUMBER 7-8
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(a)

(b)

(c)

(d)

Fig. 5 MR anatomical image of a mouse in the coronal plane. (a) The dotted line indicates the approximate location of the axial cross-sections displayed in (c) and
(d). Anatomical image in the (b) sagittal plane displaying the location of the 9L xenograft tumor (white arrow). Change in r2 relaxivity values for the tumor regions
for a mouse receiving (c) non-targeting NP-PEG-SIA and (d) targeting NP-PEG-CTX 3h post-injection. Reprinted from77. © Wiley-VCH Verlag GmbH & Co. KGaA.
Reproduced with permission.

nutrient receptors75. Many types of ligands have been investigated in

(a)

the targeting of these markers including antibodies, peptides, small
molecules, and aptamers76. A recent study by Sun et al. illustrates the
ability of targeting ligands to improve MR signal in diseased tissue77. In
this study, PEG coated SPIONs were modified with CTX. Fig. 5 shows
MR images that demonstrate tumor-specific SPION accumulation in
tumors of a 9L xenograft mouse model. In a similar approach, Fang
et al. modified SPIONs with either cyclic arginine-glycine-aspartic
acid (RGD) which targets tumor endothelial cells, or CTX78,79. SPIONs

(b)

modified with RGD (NP-RGD) or CTX (NP-CTX) show significant
increases in r2 values in tumors post injection in a xenograft U87-MG
tumor mouse model, while non-targeted control SPIONs do not.
Active targeting is not only important for improving tissue targeting
specificity, but has also been shown to improve the distribution of
SPIONs within the targeted tissue. Improved distribution of SPIONs
in vivo can be an important factor in maximizing relaxivity in tissue
and cells. SPIONs tend to accumulate and even cluster in some
specific tissue and/or cells, affecting their relaxation properties80,81.
Transverse relaxivity first increases with increased cluster size followed
by a marked decrease as cluster size continues to grow. Improved
nanoparticle distribution in tissue due to active targeting has been
demonstrated by several research groups82-84. In studies by Kievit et
al., SPIONs were modified with both DNA for gene therapy and CTX
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Fig. 6 Histology analysis of C6 xenograft tumors showing NP distribution. (a)
Prussian blue stained sections of tumors from mice treated with non-targeted
(NP:DNA) and targeted (NP:DNA-CTX) nanovectors. The scale bar corresponds
to 20 μm. (b) Images of Prussian blue stained sections at high magnification for
better visualization of nanovector localization. The non-targeted NP:DNA treated
tissue clearly shows more intense blue signals (indicating greater clustering) than
the targeted NP:DNA-CTX treated tissue. The scale bar corresponds to 5 μm.
Reprinted with permission from82. © 2010 American Chemical Society.
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(NP:DNA-CTX), with SPION/DNA as a non-targeted control (NP:DNA).

showed remarkable uptake by U87 human glioma cells in vitro and

Fig. 6 shows the reduction of SPION clustering in C6 tumors of a

excellent delineation of stereotactically injected tumors in vivo by MRI.

xenograft mouse model. The improved SPION distribution can act to

These advances in SPION design would allow for both preoperative MR

minimize any reduction in relaxivity due to large cluster formation,

imaging and intraoperative optical monitoring with a single imaging

leading to higher SNR and in turn, better delineation of tumor margins.

probe that could improve survival rates of brain tumor patients through
better delineation of tumor boundaries.
PET/MRI multimodal imaging may offer significant advantages

Multimodal imaging
SPIONs were specifically developed as an MR imaging contrast agent,

over either imaging modality alone. Several research groups have

yet advances in coating technologies have allowed for the addition of

recently developed dual PET/MRI contrast probes that combine a

other functional imaging moieties including those for optical32,85,86

SPION core with the radionuclide, Cu-64 chelated on the polymeric

(e.g., fluorophores) and nuclear

imaging83,87,88

(e.g., radionuclides).

surface of the nanoparticle83,87,88. A combined PET/MRI contrast probe

These multifunctional SPIONs can be designed to incorporate

in an integrated system could obtain near perfect spatial registration

complementary imaging modalities that synergistically provide more

of molecular/functional PET and anatomic/functional MRI89,90. This

accurate information in vivo. Each imaging modality has its advantages

combination allows highly detailed anatomical MR images to be

and limitations and no one modality can give a comprehensive snap

co-registered with PET images that currently have greater sensitivity

shot of a biological system.

to the location of contrast probes than clinical MRI87. While SPIONs

Fluorescent labeled SPIONs may serve as a platform for the next

with multimodal imaging capabilities have been developed, their full

generation of multifunctional probes for multimodality imaging. They

potential has yet to be realized due to a lack of integrated multimodal

have been developed with the goal of providing optical contrast that

imaging instrumentation.

will enable surgeons to intraoperatively distinguish cancer tissue from
healthy tissue32,85. These nanoparticles provide fluorescence through

Conclusions and outlook

the addition of numerous chromophores on the polymeric coating.

SPIONs have been extensively studied as MRI contrast agents and

SPIONs labeled with the near-infrared dye, Cy5.5, and CTX have shown

several formulations have been approved for clinical use. However, their

the ability to produce both MRI and fluorescent tumor contrast in

widespread utility has yet to be realized due to limitations of current

the brain of medulloblastoma transgenic mice (Fig. 7)32. Kumar et al.

detection limits and a lack of tissue specificity. Recent developments in

recently developed a SPION conjugated to Cy5.5 and myristoylated

both MRI acquisition methods and SPION synthesis and postsynthesis

polyarginine peptides for translocation across the

BBB79.

This probe

modifications have led to significant improvements in SPION detection
sensitivity and in vivo bio-distribution. Beyond modifications to current
MRI acquisition methods that demonstrate greater SPION sensitivity in
T2 weighted negative enhancement images, new acquisition methods
are being developed that can provide positive contrast and potentially
address current limitations of SPION contrast enhancement. These
imaging techniques take advantage of the magnetic properties of
SPIONs that are continually improving due to a better understanding
of core synthesis parameters that affect both core crystallinity and
size, as well as postsynthesis modifications that can have a dramatic
effect on their magnetic properties and in vivo behavior. In addition,
modifications of SPION surfaces with optical and nuclear imaging
probes for multimodal imaging could improve diagnosis methods by
combining the beneficial characteristics of each imaging modality.
The improvement of current detection limits is necessary for the
successful translation of newly designed SPIONs to broad clinical
application. Because of their magnetic properties and ease of
functionalization, SPIONs have gained interest as theranostic agents

Fig. 7 Ex vivo optical imaging and in vivo MR imaging of brain tumors
from a mouse treated with Cy5.5 labeled SPIONs (left) and an untreated
mouse (right). The optical spectrum gradient bar corresponds to increasing
fluorescent intensity. The color gradient bar for MR images corresponds to
increasing r2 values. Adapted with permission from32, © 2010 American
Association for Cancer Research.

capable of both providing diagnostic information and delivering
therapeutics. In addition, the use of SPIONs for cell tracking in
stem cell therapies has shown great promise. The potential of such
applications in clinical settings is dependent on the development of
highly sensitive imaging methods, as well as efficient contrast probes,
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and will only be realized with improvements to current detection limits.
Despite recent improvements to imaging methods that exploit

coatings on magnetic properties. By addressing these issues researchers
can usher in the next generation of SPIONs for MR imaging.

the magnetic properties of SPIONs, there is still a need to improve
detection of these probes in vivo. Additional research is needed to both
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